Protalix BioTherapeutics (PLX) Institutional Ownership → The ONE AI Stock to own now. (It’s not Nvidia.) (From Weiss Ratings) (Ad) Free PLX Stock Alerts $1.17 -0.06 (-4.88%) (As of 05/28/2024 ET) Add Compare Share Share OwnershipStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Protalix BioTherapeutics (NYSE:PLX)CurrentInstitutional OwnershipPercentage16.53%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$319.69KNumber ofInstitutional Sellers(last 12 months)3TotalInstitutional Outflows(last 12 months)$107.99K Get PLX Insider Trade Alerts Want to know when executives and insiders are buying or selling Protalix BioTherapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PLX Institutional Buying and Selling by Quarter Ad Weiss RatingsThe ONE AI Stock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Protalix BioTherapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/20/2024 Virtu Financial LLC157,516$198K0.0%N/A0.215% 5/7/2024 SG Americas Securities LLC21,467$27K0.0%-38.0%0.029% 5/3/2024 GSA Capital Partners LLP493,571$622K0.0%-9.3%0.673% 2/2/2024 Bailard Inc.68,100$121K0.0%N/A0.095% 1/19/2024 Denali Advisors LLC94,700$169K0.1%-14.1%0.132% 11/15/2023 GSA Capital Partners LLP496,781$825K0.1%N/A0.694% Get the Latest News and Ratings for PLX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Protalix BioTherapeutics and its competitors with MarketBeat's FREE daily newsletter. 11/13/2023 Connor Clark & Lunn Investment Management Ltd.167,536$278K0.0%+45.0%0.234% 11/7/2023 Barclays PLC46,511$77K0.0%+251.6%0.065% 10/27/2023 Allspring Global Investments Holdings LLC137,906$229K0.0%N/A0.193% 10/24/2023 Bank of New York Mellon Corp165,680$275K0.0%+12.8%0.231% 10/13/2023 SG Americas Securities LLC30,008$50K0.0%N/A0.042% 9/21/2023 Barclays PLC13,230$26K0.0%+561.5%0.018% 8/11/2023 Natixis132,000$264K0.0%N/A0.202% 8/4/2023 American International Group Inc.27,034$54K0.0%N/A0.041% 7/31/2023 Orin Green Financial LLC60,150$120K0.1%N/A0.092% 7/18/2023 Denali Advisors LLC110,200$220K0.1%N/A0.168% 5/10/2023 Connor Clark & Lunn Investment Management Ltd.158,703$333K0.0%N/A0.243% 5/9/2023 Aptus Capital Advisors LLC16,010$34K0.0%N/A0.024% 2/7/2023Commonwealth Equity Services LLC50,100$68K0.0%N/A0.101% 7/26/2022 Capital Performance Advisors LLP25,974$28K0.0%N/A0.055% 5/9/2022 Meitav Dash Investments Ltd.244,332$257K0.0%N/A0.527% 4/18/2022 Spire Wealth Management148,800$158K0.0%+18.3%0.321% 1/31/2022Commonwealth Equity Services LLC40,290$33K0.0%N/A0.088% 1/14/2022 Spire Wealth Management125,800$113K0.0%+598.9%0.276% 11/15/2021 GSA Capital Partners LLP254,871$339K0.0%N/A0.559% 11/12/2021 Credit Suisse AG31,974$43K0.0%-51.5%0.070% 8/18/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 8/17/2021 Walleye Capital LLC346,539$662K0.0%N/A0.764% 8/17/2021 Walleye Trading LLC135,000$258K0.0%N/A0.297% 8/17/2021 Bridgeway Capital Management LLC393,890$752K0.0%+30.2%0.868% 8/16/2021 Morgan Stanley1,861,819$3.56M0.0%+3,723,538.0%4.102% 8/16/2021 Credit Suisse AG65,925$126K0.0%+559.3%0.145% 8/13/2021 Renaissance Technologies LLC30,075$57K0.0%-94.1%0.066% 8/12/2021 XTX Topco Ltd17,148$33K0.0%N/A0.038% 8/11/2021Susquehanna Fundamental Investments LLC66,100$126K0.0%N/A0.146% 8/5/2021 Meitav Dash Investments Ltd.244,332$467K0.0%N/A0.538% 5/19/2021 Virtu Financial LLC27,744$124K0.0%N/A0.061% 5/18/2021Psagot Investment House Ltd.3,095,741$13.81M0.3%+558.3%6.821% 5/17/2021 Schonfeld Strategic Advisors LLC89,278$399K0.0%N/A0.197% 5/17/2021 DAFNA Capital Management LLC1,204,825$5.37M1.3%N/A2.655% Dems have chosen Biden replacement? (Ad)On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE.5/14/2021 Laurion Capital Management LP42,813$191K0.0%N/A0.094% 5/14/2021 Credit Suisse AG10,000$45K0.0%N/A0.022% 5/13/2021 Renaissance Technologies LLC507,634$2.26M0.0%+3.9%1.119% 5/10/2021 Phoenix Holdings Ltd.244,113$1.09M0.0%N/A0.538% 5/7/2021 D.A. Davidson & CO.130,700$583K0.0%N/A0.288% 4/30/2021 Ground Swell Capital LLC14,684$65K0.2%N/A0.032% 4/28/2021 DAVENPORT & Co LLC12,000$54K0.0%N/A0.026% 2/17/2021 Jane Street Group LLC22,218$81K0.0%+51.5%0.067% 2/16/2021 Squarepoint Ops LLC22,068$80K0.0%-50.6%0.066% 2/4/2021 GSA Capital Partners LLP10,042$36K0.0%N/A0.030% 11/17/2020 Jane Street Group LLC14,661$57K0.0%-89.8%0.044% 11/16/2020 Squarepoint Ops LLC44,679$173K0.0%N/A0.134% 11/12/2020 Arrowstreet Capital Limited Partnership45,853$177K0.0%+32.3%0.138% 11/10/2020 Phoenix Holdings Ltd.204,355$751K0.0%+8.5%0.613% 8/31/2020 Bridgeway Capital Management Inc.174,291$661K0.0%+94.8%0.537% 8/17/2020 Jane Street Group LLC143,821$542K0.0%+185.6%0.443% 8/12/2020 Bank of Montreal Can173,704$615K0.0%N/A0.535% 8/10/2020 Phoenix Holdings Ltd.188,336$681K0.0%N/A0.581% 7/29/2020Psagot Investment House Ltd.470,255$1.73M0.0%+15.7%1.450% 5/15/2020 Jane Street Group LLC50,352$124K0.0%+53.4%0.339% (Data available from 1/1/2016 forward) PLX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PLX shares? During the previous two years, 15 institutional investors and hedge funds held shares of Protalix BioTherapeutics. The most heavily invested institutionals were GSA Capital Partners LLP ($622K), Connor Clark & Lunn Investment Management Ltd. ($278K), Bank of New York Mellon Corp ($275K), Natixis ($264K), Allspring Global Investments Holdings LLC ($229K), Virtu Financial LLC ($198K), and Denali Advisors LLC ($169K).Learn more on PLX's institutional investors. What percentage of Protalix BioTherapeutics stock is owned by institutional investors? 16.53% of Protalix BioTherapeutics stock is owned by institutional investors. Learn more on PLX's institutional investor holdings. Which institutional investors have been buying Protalix BioTherapeutics stock? Of the 15 institutional investors that purchased Protalix BioTherapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: GSA Capital Partners LLP ($496.78K), Connor Clark & Lunn Investment Management Ltd. ($210.70K), Virtu Financial LLC ($157.52K), Allspring Global Investments Holdings LLC ($137.91K), Natixis ($132K), Denali Advisors LLC ($110.20K), and Bailard Inc. ($68.10K). How much institutional buying is happening at Protalix BioTherapeutics? Institutional investors have bought a total of 1,585,750 shares in the last 24 months. This purchase volume represents approximately $811.85K in transactions. Which Protalix BioTherapeutics major shareholders have been selling company stock? The following institutional investors have sold Protalix BioTherapeutics stock in the last 24 months: GSA Capital Partners LLP ($50.67K), Denali Advisors LLC ($15.50K), and SG Americas Securities LLC ($13.14K). How much institutional selling is happening at Protalix BioTherapeutics? Institutional investors have sold a total of 79,306 shares in the last 24 months. This volume of shares sold represents approximately $107.99K in transactions. Related Companies: AlloVir Major Shareholders Atara Biotherapeutics Major Shareholders Cognition Therapeutics Major Shareholders Elutia Major Shareholders bluebird bio Major Shareholders BioAtla Major Shareholders Instil Bio Major Shareholders DBV Technologies Major Shareholders CEL-SCI Major Shareholders LENZ Therapeutics Major Shareholders This page (NYSE:PLX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaWARNING about the death of the U.S. dollar…Colonial MetalsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersWall Street Legend Warns: "A Strange Day Is Coming to America"Chaikin AnalyticsHe Is Giving Away BitcoinCrypto Swap ProfitsElon’s New Device is About to Shock the WorldInvestorPlaceDigitizing the $11T commodities sector with one tiny stockResource Stock DigestTim Sykes’ Urgent Trade Alert: “Make this move now”Timothy Sykes Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Protalix BioTherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.